Nesina Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones"
Phase of Trial: Phase IV
Latest Information Update: 11 Mar 2017
At a glance
- Drugs Alogliptin (Primary) ; Thiazolidinediones
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Takeda
- 10 Jun 2017 Biomarkers information updated
- 07 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 24 Sep 2013 New trial record